|
RAD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.904350E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.624200E-03 |
| Normal-vs-Stage2 |
9.016600E-03 |
| Normal-vs-Stage3 |
7.374200E-02 |
| Normal-vs-Stage4 |
9.102200E-01 |
| Stage1-vs-Stage2 |
6.476400E-01 |
| Stage1-vs-Stage3 |
2.730400E-01 |
| Stage1-vs-Stage4 |
6.485600E-02 |
| Stage2-vs-Stage3 |
2.704600E-01 |
| Stage2-vs-Stage4 |
6.370400E-02 |
| Stage3-vs-Stage4 |
2.367800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.398800E-03 |
| Normal-vs-AfricanAmerican |
5.017400E-01 |
| Normal-vs-Asian |
8.876400E-01 |
| Caucasian-vs-AfricanAmerican |
3.670200E-02 |
| Caucasian-vs-Asian |
5.496400E-02 |
| AfricanAmerican-vs-Asian |
4.714800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.261830E-02 |
| Normal-vs-Female |
1.222080E-02 |
| Male-vs-Female |
5.697800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.123650E-02 |
| Normal-vs-Age(41-60Yrs) |
1.377510E-02 |
| Normal-vs-Age(61-80Yrs) |
7.223800E-02 |
| Normal-vs-Age(81-100Yrs) |
3.356400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.944400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.523200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.536400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.727000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.608600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.892800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.386400E-01 |
| Classical-VS-Follicular |
2.65399999999083E-06 |
| Classical-VS-Other |
4.493600E-01 |
| Classical-VS-Normal |
2.397400E-01 |
| Tall-VS-Follicular |
2.213700E-02 |
| Tall-VS-Other |
7.237400E-01 |
| Tall-VS-Normal |
6.450500E-02 |
| Follicular-VS-Other |
4.444600E-01 |
| Follicular-VS-Normal |
1.92319999999802E-05 |
| Other-VS-Normal |
1.768610E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.390700E-04 |
| Normal-vs-N1 |
4.783600E-01 |
| N0-vs-N1 |
3.007800E-02 |
|
|
